Louis P. Lacasse, Director at Conatus Pharmaceuticals Inc (CNAT), bought 809,887 shares at $11.00 ($1.5M) on 2013-07-30, disclosed to the SEC on 2013-08-01.
Open-market purchase of $1.5M CNAT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 673,400 | $0 | 0.0% |
| 2 | $11.00 | 12,537 | $138K | 9.2% |
| 3 | $11.00 | 123,950 | $1.4M | 90.8% |
| Total | $1.85 avg | 809,887 | $1.5M | 100% |